Candesartan ameliorates impaired fear extinction induced by innate immune activation

Brain, Behavior, and Immunity

Volumn 52, Issue , 2016, Pages 169-177

  Quiñones, María M ^a   Maldonado, Lizette ^b   Velazquez, Bethzaly ^c   Porter, James T ^c  

^a PONCE HEALTH SCIENCES UNIVERSITY   (Puerto Rico)

^b Pontifical Catholic University of Puerto Rico   (Puerto Rico)

^c PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Amygdala; Angiotensin; Extinction; Lipopolysaccharide; Medial prefrontal cortex

Indexed keywords

CANDESARTAN; BENZIMIDAZOLE DERIVATIVE; LIPOPOLYSACCHARIDE; TETRAZOLE DERIVATIVE;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; FEAR; INNATE IMMUNITY; LEARNING; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RECALL; REINFORCEMENT; ANIMAL; ANIMAL MODEL; ASSOCIATION; DRUG EFFECTS; IMMUNOLOGY; MENTAL STRESS; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; BENZIMIDAZOLES; CONDITIONING (PSYCHOLOGY); CUES; EXTINCTION, PSYCHOLOGICAL; FEAR; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MALE; MENTAL RECALL; MODELS, ANIMAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; TETRAZOLES;

EID: 84953264835     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.10.017     Document Type: Article

References (60)

1. Adcock I.M., Ito K., Barnes P.J. Glucocorticoids: effects on gene transcription. Proc. Am. Thorac. Soc. 2004, 1:247-254. 10.1513/pats.200402-001MS.
2. Amano T., Unal C.T., Paré D. Synaptic correlates of fear extinction in the amygdala. Nat. Neurosci. 2010, 13:489-494. 10.1038/nn.2499.
3. Andrews J.A., Neises K.D. Cells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central disease. J. Neurochem. 2012, 120:26-36. 10.1111/j.1471-4159.2011.07545.x.
4. Asnis G.M., Kohn S.R., Henderson M., Brown N.L. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs 2004, 64:383-404.
5. Benicky J., Sánchez-Lemus E., Honda M., Pang T., Orecna M., Wang J., Leng Y., Chuang D.-M., Saavedra J.M. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 2011, 36:857-870. 10.1038/npp.2010.225.
6. Bierer L.M., Tischler L., Labinsky E., Cahill S., Foa E., Yehuda R. Clinical correlates of 24-h cortisol and norepinephrine excretion among subjects seeking treatment following the world trade center attacks on 9/11. Ann. N.Y. Acad. Sci. 2006, 1071:514-520. 10.1196/annals.1364.055.
7. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 1972, 81:281-290.
8. Choi D.-Y., Lee J.W., Lin G., Lee Y.K., Lee Y.H., Choi I.S., Han S.B., Jung J.K., Kim Y.H., Kim K.H., Oh K.-W., Hong J.T., Lee M.S. Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway. Neurochem. Int. 2012, 60:68-77. 10.1016/j.neuint.2011.11.005.
9. Cohen H., Kozlovsky N., Matar M.A., Zohar J., Kaplan Z. The characteristic long-term upregulation of hippocampal NF-κB complex in PTSD-like behavioral stress response is normalized by high-dose corticosterone and pyrrolidine dithiocarbamate administered immediately after exposure. Neuropsychopharmacology 2011, 36:2286-2302. 10.1038/npp.2011.118.
10. Cunningham C., Sanderson D.J. Malaise in the water maze: untangling the effects of LPS and IL-1beta on learning and memory. Brain Behav. Immun. 2008, 22:1117-1127. 10.1016/j.bbi.2008.05.007.
11. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56. 10.1038/nrn2297.
12. De Kloet C.S., Vermetten E., Geuze E., Kavelaars A., Heijnen C.J., Westenberg H.G.M. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J. Psychiatr. Res. 2006, 40:550-567. 10.1016/j.jpsychires.2005.08.002.
13. Engler H., Doenlen R., Engler A., Riether C., Prager G., Niemi M.-B., Pacheco-López G., Krügel U., Schedlowski M. Acute amygdaloid response to systemic inflammation. Brain. Behav. Immun. 2011, 25:1384-1392. 10.1016/j.bbi.2011.04.005.
14. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 2003, 100:171-194.
15. Gill J., Vythilingam M., Page G.G. Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD. J. Trauma. Stress 2008, 21:530-539. 10.1002/jts.20372.
16. Godsil B.P., Kiss J.P., Spedding M., Jay T.M. The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?. Eur. Neuropsychopharmacol. 2013, 23:1165-1181. 10.1016/j.euroneuro.2012.10.018.
17. Gola H., Engler H., Sommershof A., Adenauer H., Kolassa S., Schedlowski M., Groettrup M., Elbert T., Kolassa I.-T. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 2013, 13:40. 10.1186/1471-244X-13-40.
18. Gonzalez P., Machado I., Vilcaes A., Caruso C., Roth G.A., Schiöth H., Lasaga M., Scimonelli T. Molecular mechanisms involved in interleukin 1-beta (IL-1β)-induced memory impairment. modulation by alpha-melanocyte-stimulating hormone (α-MSH). Brain Behav. Immun. 2013, 34:141-150. 10.1016/j.bbi.2013.08.007.
19. Guo M., Liu T., Guo J.-C., Jiang X.-L., Chen F., Gao Y.-S. Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac. J. Trop. Med. 2012, 5:323-325. 10.1016/S1995-7645(12)60048-0.
20. Haba R., Shintani N., Onaka Y., Wang H., Takenaga R., Hayata A., Baba A., Hashimoto H. Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: possible role of activation of the central amygdala. Behav. Brain Res. 2012, 228:423-431. 10.1016/j.bbr.2011.12.027.
21. Jakovljević M., Brajković L., Lončar M., Cima A. Posttraumatic stress disorders (PTSD) between fallacy and facts: what we know and what we don't know?. Psychiatr. Danub. 2012, 24:241-245.
22. Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013, 53:52-62. 10.1016/j.mcn.2012.10.002.
23. Kim J.H., Li S., Richardson R. Immunohistochemical analyses of long-term extinction of conditioned fear in adolescent rats. Cereb. Cortex 2011, 21:530-538. 10.1093/cercor/bhq116.
24. Khoury N.M., Marvar P.J., Gillespie C.F., Wingo A., Schwartz A., Bradley B., Kramer M., Ressler K.J. The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J. Clin. Psychiatry 2012, 73:849-855. 10.4088/JCP.11m07316.
25. Kranjac D., McLinden K.A., Deodati L.E., Papini M.R., Chumley M.J., Boehm G.W. Peripheral bacterial endotoxin administration triggers both memory consolidation and reconsolidation deficits in mice. Brain Behav. Immun. 2012, 26:109-121. 10.1016/j.bbi.2011.08.005.
26. Kurtz T.W., Klein U. Next generation multifunctional angiotensin receptor blockers. Hypertens. Res. 2009, 32:826-834. 10.1038/hr.2009.135.
27. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 1988, 8:2517-2529.
28. Lindqvist D., Wolkowitz O.M., Mellon S., Yehuda R., Flory J.D., Henn-Haase C., Bierer L.M., Abu-Amara D., Coy M., Neylan T.C., Makotkine I., Reus V.I., Yan X., Taylor N.M., Marmar C.R., Dhabhar F.S. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav. Immun. 2014, 42:81-88. 10.1016/j.bbi.2014.06.003.
29. Marvar P.J., Goodman J., Fuchs S., Choi D.C., Banerjee S., Ressler K.J. Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol. Psychiatry 2014, 75:864-872. 10.1016/j.biopsych.2013.08.024.
30. McCallum J., Kim J.H., Richardson R. Impaired extinction retention in adolescent rats: effects of d-cycloserine. Neuropsychopharmacology 2010, 35:2134-2142. 10.1038/npp.2010.92.
31. McNally G.P., Johansen J.P., Blair H.T. Placing prediction into the fear circuit. Trends Neurosci. 2011, 34:283-292. 10.1016/j.tins.2011.03.005.
32. Milad M.R., Quirk G.J. Fear extinction as a model for translational neuroscience: ten years of progress. Annu. Rev. Psychol. 2012, 63:129-151. 10.1146/annurev.psych.121208.131631.
33. Milad M.R., Pitman R.K., Ellis C.B., Gold A.L., Shin L.M., Lasko N.B., Zeidan M.A., Handwerger K., Orr S.P., Rauch S.L. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol. Psychiatry 2009, 66:1075-1082. 10.1016/j.biopsych.2009.06.026.
34. Min L.-J., Mogi M., Shudou M., Jing F., Tsukuda K., Ohshima K., Iwanami J., Horiuchi M. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension 2012, 59:1079-1088. 10.1161/HYPERTENSIONAHA.112.192401.
35. Miyoshi M., Miyano K., Moriyama N., Taniguchi M., Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation. Eur. J. Neurosci. 2008, 27:343-351. 10.1111/j.1460-9568.2007.06014.x.
36. Nishimura Y., Ito T., Saavedra J.M. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000, 31:2478-2486.
37. Orsini C.A., Maren S. Neural and cellular mechanisms of fear and extinction memory formation. Neurosci. Biobehav. Rev. 2012, 36:1773-1802. 10.1016/j.neubiorev.2011.12.014.
38. Pace T.W.W., Heim C.M. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain. Behav. Immun. 2011, 25:6-13. 10.1016/j.bbi.2010.10.003.
39. Pace T.W.W., Wingenfeld K., Schmidt I., Meinlschmidt G., Hellhammer D.H., Heim C.M. Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder. Brain. Behav. Immun. 2012, 26:13-17. 10.1016/j.bbi.2011.07.232.
40. Pattwell S.S., Duhoux S., Hartley C.A., Johnson D.C., Jing D., Elliott M.D., Ruberry E.J., Powers A., Mehta N., Yang R.R. Altered fear learning across development in both mouse and human. Proc. Natl. Acad. Sci. 2012, 109:16318-16323. 10.1073/pnas.1206834109.
41. Phillips M.I., Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Curr. Opin. Investig. Drugs 2002, 3:569-577.
42. Prager G., Hadamitzky M., Engler A., Doenlen R., Wirth T., Pacheco-López G., Krügel U., Schedlowski M., Engler H. Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B. J. Neuroimmune Pharmacol. 2013, 8:42-50. 10.1007/s11481-012-9373-0.
43. Pugh C.R., Kumagawa K., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav. Immun. 1998, 12:212-229. 10.1006/brbi.1998.0524.
44. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33:56-72. 10.1038/sj.npp.1301555.
45. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 2004, 55:745-751. 10.1016/j.biopsych.2003.11.018.
46. Rosen C.S., Greenbaum M.A., Schnurr P.P., Holmes T.H., Brennan P.L., Friedman M.J. Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder?. J. Clin. Psychiatry 2013, 74:1241-1248. 10.4088/JCP.13m08592.
47. Sánchez-Lemus E., Benicky J., Pavel J., Saavedra J.M. In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland. Brain Behav. Immun. 2009, 23:945-957. 10.1016/j.bbi.2009.04.012.
48. Savoia C., Schiffrin E.L. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin. Sci. (Lond.) 2007, 112:375-384. 10.1042/CS20060247.
49. Schelling G., Roozendaal B., Krauseneck T., Schmoelz M., Quervain D.E., Briegel J. Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery. Ann. N.Y. Acad. Sci. 2006, 1071:46-53. 10.1196/annals.1364.005.
50. Schupp M., Janke J., Clasen R., Unger T., Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 2004, 109:2054-2057. 10.1161/01.CIR.0000127955.36250.65.
51. Sierra-Mercado D., Padilla-Coreano N., Quirk G.J. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011, 36:529-538. 10.1038/npp.2010.184.
52. Smith A.K., Conneely K.N., Kilaru V., Mercer K.B., Weiss T.E., Bradley B., Tang Y., Gillespie C.F., Cubells J.F., Ressler K.J. Differential immune system DNA methylation and cytokine regulation in post-traumatic stress disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2011, 156B:700-708. 10.1002/ajmg.b.31212.
53. Tsukuda K., Mogi M., Iwanami J., Min L.-J., Sakata A., Jing F., Iwai M., Horiuchi M. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 2009, 54:782-787. 10.1161/HYPERTENSIONAHA.109.136879.
54. Van Zuiden M., Geuze E., Willemen H.L.D.M., Vermetten E., Maas M., Amarouchi K., Kavelaars A., Heijnen C.J. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol. Psychiatry 2012, 71:309-316. 10.1016/j.biopsych.2011.10.026.
55. Von Känel R., Hepp U., Kraemer B., Traber R., Keel M., Mica L., Schnyder U. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 2007, 41:744-752. 10.1016/j.jpsychires.2006.06.009.
56. Wu C.-W., Chen Y.-C., Yu L., Chen H., Jen C.J., Huang A.-M., Tsai H.-J., Chang Y.-T., Kuo Y.-M. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. J. Neurochem. 2007, 103:2471-2481. 10.1111/j.1471-4159.2007.04987.x.
57. Yang C., Hong T., Shen J., Ding J., Dai X.-W., Zhou Z.-Q., Yang J.-J. Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus. Exp. Ther. Med. 2013, 5:1093-1096. 10.3892/etm.2013.930.
58. Yehuda R., Golier J.A., Kaufman S. Circadian rhythm of salivary cortisol in Holocaust survivors with and without PTSD. Am. J. Psychiatry 2005, 162:998-1000. 10.1176/appi.ajp.162.5.998.
59. Yin P., Li Z., Wang Y.-Y., Qiao N.-N., Huang S.-Y., Sun R.-P., Wang J.-W. Neonatal immune challenge exacerbates seizure-induced hippocampus-dependent memory impairment in adult rats. Epilepsy Behav. 2013, 27:9-17. 10.1016/j.yebeh.2012.12.015.
60. Zieker J., Zieker D., Jatzko A., Dietzsch J., Nieselt K., Schmitt A., Bertsch T., Fassbender K., Spanagel R., Northoff H., Gebicke-Haerter P.J. Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol. Psychiatry 2007, 12:116-118. 10.1038/sj.mp.4001905.